Rani Therapeutics Holdings RANI
NASDAQ RANI
$0.57 +0.01 (+1.41%)
At close: Nov 11, 2026 · 4:00 PM EST

Rani Therapeutics Holdings (RANI) Total Non-Current Liabilities (2024 - 2026)

Updated

Analysis

Rani Therapeutics Holdings (RANI) Total Non-Current Liabilities (2024 - 2026) Analysis & Trends

Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Total Non-Current Liabilities (Qtr)
1 Eli Lilly 1,348.13 Bn 1,321.74 Bn 20.46 Bn 60.81 Bn
2 Johnson & Johnson 675.90 Bn 595.76 Bn 17.30 Bn 102.65 Bn
3 AbbVie 519.45 Bn 487.50 Bn 13.12 Bn 117.60 Bn
4 Merck 364.95 Bn 327.95 Bn 13.19 Bn 79.95 Bn
5 Novartis Ag 311.58 Bn 285.16 Bn - -
6 Astrazeneca 289.34 Bn 262.94 Bn 13.26 Bn -36.84 Bn
7 Amgen 251.64 Bn 203.30 Bn 7.58 Bn 76.12 Bn
8 Gilead Sciences 212.05 Bn 187.07 Bn 6.73 Bn 36.05 Bn
9 Pfizer 167.35 Bn 115.00 Bn 12.56 Bn 96.04 Bn
10 Rani Therapeutics Holdings 111.44 Mn -41.89 Mn - 10.87 Mn
Historic Data

Historic Data

Download Data
DateValue
Sep 30, 2026 10.87 Mn
Jun 30, 2026 12.54 Mn
Mar 31, 2026 16.01 Mn
Dec 31, 2025 16.77 Mn
Dec 31, 2024 32.81 Mn
API Access

Rani Therapeutics Holdings Total Non-Current Liabilities API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=total-non-current-liabilities&ticker=RANI&period=max&api_key=YOUR_API_KEY